Literature DB >> 35233098

Hundreds of COVID trials could provide a deluge of new drugs.

Heidi Ledford.   

Abstract

Entities:  

Keywords:  Drug discovery; SARS-CoV-2; Therapeutics

Mesh:

Substances:

Year:  2022        PMID: 35233098     DOI: 10.1038/d41586-022-00562-0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  2 in total

1.  β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.

Authors:  Shuntai Zhou; Collin S Hill; Sanjay Sarkar; Longping V Tse; Blaide M D Woodburn; Raymond F Schinazi; Timothy P Sheahan; Ralph S Baric; Mark T Heise; Ronald Swanstrom
Journal:  J Infect Dis       Date:  2021-08-02       Impact factor: 5.226

2.  Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.

Authors:  Kris M White; Romel Rosales; Soner Yildiz; Thomas Kehrer; Lisa Miorin; Elena Moreno; Sonia Jangra; Melissa B Uccellini; Raveen Rathnasinghe; Lynda Coughlan; Carles Martinez-Romero; Jyoti Batra; Ajda Rojc; Mehdi Bouhaddou; Jacqueline M Fabius; Kirsten Obernier; Marion Dejosez; María José Guillén; Alejandro Losada; Pablo Avilés; Michael Schotsaert; Thomas Zwaka; Marco Vignuzzi; Kevan M Shokat; Nevan J Krogan; Adolfo García-Sastre
Journal:  Science       Date:  2021-01-25       Impact factor: 47.728

  2 in total
  6 in total

Review 1.  Recent advances in small-molecular therapeutics for COVID-19.

Authors:  Lei Zhong; Zhipeng Zhao; Xuerun Peng; Jun Zou; Shengyong Yang
Journal:  Precis Clin Med       Date:  2022-09-24

2.  Epidemic spreading under mutually independent intra- and inter-host pathogen evolution.

Authors:  Stefano Boccaletti; Baruch Barzel; Xiyun Zhang; Zhongyuan Ruan; Muhua Zheng; Jie Zhou
Journal:  Nat Commun       Date:  2022-10-20       Impact factor: 17.694

Review 3.  Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework.

Authors:  Laure-Alix Clerbaux; Maria Cristina Albertini; Núria Amigó; Anna Beronius; Gillina F G Bezemer; Sandra Coecke; Evangelos P Daskalopoulos; Giusy Del Giudice; Dario Greco; Lucia Grenga; Alberto Mantovani; Amalia Muñoz; Elma Omeragic; Nikolaos Parissis; Mauro Petrillo; Laura A Saarimäki; Helena Soares; Kristie Sullivan; Brigitte Landesmann
Journal:  J Clin Med       Date:  2022-07-31       Impact factor: 4.964

4.  Experience Using Paxlovid for Patients With Coronavirus Disease 2019 in a Resource-Limited Emergency Department.

Authors:  Rahul V Nene; Michael R Navarro; Christian A Tomaszewski; Andrew Lafree
Journal:  Ann Emerg Med       Date:  2022-10       Impact factor: 6.762

5.  Efficacy of SARS-CoV-2 Vaccination in Dialysis Patients: Epidemiological Analysis and Evaluation of the Clinical Progress.

Authors:  Giovanni Mosconi; Michela Fantini; Matteo Righini; Marta Flachi; Simona Semprini; Lilio Hu; Francesca Chiappo; Barbara Veterani; Katia Ambri; Franca Ferrini; Catia Milanesi; Antonio Giudicissi; Gaetano La Manna; Angelo Rigotti; Andrea Buscaroli; Vittorio Sambri; Maria Cappuccilli
Journal:  J Clin Med       Date:  2022-08-12       Impact factor: 4.964

6.  A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment.

Authors:  Titilayo Omolara Johnson; Abayomi Emmanuel Adegboyega; Oluwafemi Adeleke Ojo; Amina Jega Yusuf; Opeyemi Iwaloye; Chinenye Jane Ugwah-Oguejiofor; Rita Onyekachukwu Asomadu; Ifeoma Felicia Chukwuma; Stephen Adakole Ejembi; Emmanuel Ike Ugwuja; Saqer S Alotaibi; Sarah M Albogami; Gaber El-Saber Batiha; Bodour S Rajab; Carlos Adam Conte-Junior
Journal:  Front Med (Lausanne)       Date:  2022-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.